Alere fell 3 percent Friday after it sued Abbott Laboratories to compel it to get all antitrust approvals required to complete its $5.8 billion merger deal. » Read More
Ulta gave third-quarter guidance below analyst expectations, despite reporting earnings and sales growth that topped estimates.
CNBC Pro highlights the top-performing stocks this week and analyzes whether the good times will continue.
Zev Spiro of Orips Research tells CNBC why he believes oil could rise above $70.
Telsey Advisory Group lowers its rating for Viacom, citing the prospects of a credit rating downgrade or dividend cut.
Stellar inflows into fixed income this week has caused one investment bank to warn of a "bond shock" in the coming months.
Wall Street likes health care despite its vulnerability to political headwinds and underperformance this year.
Cloud company Rackspace on Friday announced that it has entered into a $4.3 billion cash deal to become a private company.
Herbalife shares slumped after Bill Ackman said he was approached to take a stake in the firm.
This month's moderate rebound in the oil price is likely to cool next year, according to analysts at Bank of America Merrill Lynch.
But St. Louis Fed President James Bullard wouldn't be firm, saying he would like to raise rates on good economic news.
Jim Cramer says executive embarrassment and presidential candidate tweets won’t solve the EpiPen problem.
Some of the names on the move ahead of the open.
Jim Cramer says it's time for Apple to put its massive $231 billion cash hoard to work, and buy this company.
Shares of St. Jude Medical briefly fell more than 8 percent Thursday after Muddy Waters Capital announced the firm is short the stock.
Shares of two jewelers were on the move Thursday after reporting quarterly earnings.
Did you predict that oil would bounce in 2016? Nice! Did you attempt to cash in by buying the biggest oil ETF? Uh-oh.
Get the best of CNBC in your inbox